NCT00000559View on ClinicalTrials.gov

Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 1995

Study Completion Date

August 31, 2001

Conditions

Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial IschemiaPostmenopause

Interventions

DRUG

estrogen replacement therapy

DRUG

hormone replacement therapy

DRUG

estradiol

DRUG

medroxyprogesterone

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH